{"entity":{"type":"insider","cik":"0001806147","url":"/insider/0001806147","json_url":"/insider/0001806147.json","name":"Bailey John E. (Jack) Jr.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":8,"first":"2020-11-13","last":"2024-07-08","span_basis":"filed_date"},"name_variants":[{"name":"Bailey John E. (Jack) Jr.","source":"filing","n_filings":8,"first_seen":"2020-11-13","last_seen":"2024-07-08"}],"transactions":[{"id":2967354,"accession":"0001562180-24-005655","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-005655","line_url":"/filing/0001562180-24-005655#line-1","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001806147","owner_name":"Bailey John E. (Jack) Jr.","owner_display_name":"Bailey John E. (Jack) Jr.","owner_url":"/insider/0001806147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7662.0,"shares_display":"7,662","price_per_share":2.5077,"price_display":"2.51","price_state":"stated","total_value":19213.9974,"total_display":"19,214.00","total_whole":"19,214","shares_owned_after":549674.0,"shares_owned_after_display":"549,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-05","filed_date":"2024-07-08","scope":"insider"},{"id":2729330,"accession":"0001562180-24-004056","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-004056","line_url":"/filing/0001562180-24-004056#line-1","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001806147","owner_name":"Bailey John E. (Jack) Jr.","owner_display_name":"Bailey John E. (Jack) Jr.","owner_url":"/insider/0001806147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37258.0,"shares_display":"37,258","price_per_share":4.7888,"price_display":"4.79","price_state":"stated","total_value":178421.1104,"total_display":"178,421.11","total_whole":"178,421","shares_owned_after":452336.0,"shares_owned_after_display":"452,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-13","filed_date":"2024-05-15","scope":"insider"},{"id":2288046,"accession":"0001562180-24-000324","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-24-000324","line_url":"/filing/0001562180-24-000324","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001806147","owner_name":"Bailey John E. (Jack) Jr.","owner_display_name":"Bailey John E. (Jack) Jr.","owner_url":"/insider/0001806147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11686.0,"shares_display":"11,686","price_per_share":3.1189,"price_display":"3.12","price_state":"stated","total_value":36447.4654,"total_display":"36,447.47","total_whole":"36,447","shares_owned_after":489594.0,"shares_owned_after_display":"489,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-08","scope":"insider","n_lines":2},{"id":3082528,"accession":"0001562180-24-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-000046","line_url":"/filing/0001562180-24-000046#line-1","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001806147","owner_name":"Bailey John E. (Jack) Jr.","owner_display_name":"Bailey John E. (Jack) Jr.","owner_url":"/insider/0001806147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32983.0,"shares_display":"32,983","price_per_share":3.2746,"price_display":"3.27","price_state":"stated","total_value":108006.1318,"total_display":"108,006.13","total_whole":"108,006","shares_owned_after":400580.0,"shares_owned_after_display":"400,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-02","filed_date":"2024-01-02","scope":"insider"},{"id":8398556,"accession":"0001562180-23-005812","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-005812","line_url":"/filing/0001562180-23-005812#line-1","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001806147","owner_name":"Bailey John E. (Jack) Jr.","owner_display_name":"Bailey John E. (Jack) Jr.","owner_url":"/insider/0001806147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2719.0,"shares_display":"2,719","price_per_share":2.4537,"price_display":"2.45","price_state":"stated","total_value":6671.6103,"total_display":"6,671.61","total_whole":"6,672","shares_owned_after":433563.0,"shares_owned_after_display":"433,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-05","filed_date":"2023-07-07","scope":"insider"},{"id":8301522,"accession":"0001562180-23-000249","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-23-000249","line_url":"/filing/0001562180-23-000249#line-3","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001806147","owner_name":"Bailey John E. (Jack) Jr.","owner_display_name":"Bailey John E. (Jack) Jr.","owner_url":"/insider/0001806147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5607.0,"shares_display":"5,607","price_per_share":5.5756,"price_display":"5.58","price_state":"stated","total_value":31262.3892,"total_display":"31,262.39","total_whole":"31,262","shares_owned_after":276282.0,"shares_owned_after_display":"276,282","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-05","scope":"insider"},{"id":8301518,"accession":"0001562180-23-000249","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-000249","line_url":"/filing/0001562180-23-000249#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001806147","owner_name":"Bailey John E. (Jack) Jr.","owner_display_name":"Bailey John E. (Jack) Jr.","owner_url":"/insider/0001806147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32019.0,"shares_display":"32,019","price_per_share":5.8544,"price_display":"5.85","price_state":"stated","total_value":187452.0336,"total_display":"187,452.03","total_whole":"187,452","shares_owned_after":281889.0,"shares_owned_after_display":"281,889","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-05","scope":"insider"},{"id":6950789,"accession":"0001562180-22-000302","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-22-000302","line_url":"/filing/0001562180-22-000302#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001806147","owner_name":"Bailey John E. (Jack) Jr.","owner_display_name":"Bailey John E. (Jack) Jr.","owner_url":"/insider/0001806147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34125.0,"shares_display":"34,125","price_per_share":10.4106,"price_display":"10.41","price_state":"stated","total_value":355261.725,"total_display":"355,261.72","total_whole":"355,262","shares_owned_after":233208.0,"shares_owned_after_display":"233,208","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-05","scope":"insider"},{"id":2824600,"accession":"0001562180-20-006693","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-006693","line_url":"/filing/0001562180-20-006693#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001806147","owner_name":"Bailey John E. (Jack) Jr.","owner_display_name":"Bailey John E. (Jack) Jr.","owner_url":"/insider/0001806147","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":12.83,"price_display":"12.83","price_state":"stated","total_value":51320.0,"total_display":"51,320.00","total_whole":"51,320","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-13","scope":"insider"},{"id":2824598,"accession":"0001562180-20-006693","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-20-006693","line_url":"/filing/0001562180-20-006693#line-1","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001806147","owner_name":"Bailey John E. (Jack) Jr.","owner_display_name":"Bailey John E. (Jack) Jr.","owner_url":"/insider/0001806147","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":12.7637,"price_display":"12.76","price_state":"stated","total_value":51054.8,"total_display":"51,054.80","total_whole":"51,055","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001560241","name":"G1 Therapeutics, Inc.","url":"/issuer/0001560241","role":"Director, Officer (President and CEO)","n_filings":8,"first_seen":"2020-11-13","last_seen":"2024-07-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001806147","retrieved_at":"2026-08-23T13:48:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}